Nebenwirkungen · Kyprolis
Kyprolis 10 mg powder for solution for infusion Kyprolis 30 mg powder for solution for infusion Kyprolis 60 mg powder for solution for infusion · Abschnitt 4.8 · PDF-Seite 16
HOS-131568 · Präparat HOS-097095
MedDRA system Very common Common Uncommon Rare organ class (≥ 1/10) (≥ 1/100 to < 1/10) (≥ 1/1 000 to < 1/100) (≥ 1/10 000 to < 1/1 000) Infections and Pneumonia Sepsis Clostridium difficile infestations Respiratory tract Lung infection colitis infection Influenza Cytomegalovirus Herpes zoster* infection Urinary tract infection Hepatitis B virus Bronchitis reactivation Gastroenteritis Viral infection Nasopharyngitis Rhinitis Immune system Drug hypersensitivity disorders Blood and Thrombocytopenia Febrile neutropenia HUS Thrombotic lymphatic system Neutropenia TTP microangiopathy disorders Anaemia Lymphopenia Leukopenia Metabolism and Hypokalaemia Dehydration Tumour lysis nutrition disorders Decreased appetite Hyperkalaemia syndrome Hypomagnesaemia Hyponatraemia Hypercalcaemia Hypocalcaemia Hypophosphataemia Hyperuricaemia Hypoalbuminaemia Hyperglycaemia
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-05T09:44:00Z · SHA-256 38eb50526ebf9676627baab9145f1c776e888dbba62df61d78a0f63994b9687a · Passage 4580c84d78a6abc23131ed8c5063e8433e8927cfac5eeb8215fca6482c4da98c · Zeichen 3069–5086 im Abschnitt